Used in the treatment of chronic lymphocytic leukemia (CLL) and multiple sclerosis (MS). Targets CD20 protein on B cells, leading to their depletion, which helps control autoimmune activity and malignant cell growth. Administered intravenously, it reduces disease progression by modulating the immune system. Also investigated for use in other B-cell-related disorders and autoimmune conditions.